Avid Bioservices (NASDAQ:CDMO) Sets New 12-Month Low Following Analyst Downgrade

Avid Bioservices, Inc. (NASDAQ:CDMO – Get Free Report)’s stock price reached a new 52-week low during trading on Friday after Royal Bank of Canada lowered their price target on the stock from $17.00 to $15.00. The stock traded as low as $10.08 and last traded at $10.58, with a volume of 63865 shares changing hands. […]

Related Keywords

Blackrock ,Nova Scotia ,Canada ,Richarda Richieri , ,Securities Exchange Commission ,T Rowe Price Investment Management Inc ,Vanguard Group Inc ,Blackrock Inc ,Nasdaq ,Avid Bioservices Company Profile ,Avid Bioservices Inc ,Altravue Capital ,Royal Bank ,Avid Bioservices ,Get Free Report ,Stewart Green ,Exchange Commission ,Street Corp ,Rowe Price Investment Management ,Vue Capital ,Avid Bioservices Daily ,Nasdaq Cdmo ,Cdmo ,Medical ,Stocks ,Technicals ,